EUVIMED · CrossrefJournal
EJC Skin Cancer
ISSN 2772-6118 · Elsevier BV
Latest articles
Modality-Specific Prognostic and Predictive Factors in Metastatic Uveal Melanoma
Metastatic Spiradenocarcinoma Successfully Treated With Combined Ipilimumab and Nivolumab
Erratum to “Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study” [EJC Skin Cancer 4 (2026) 100773]
Erratum to “Prognostic and predictive importance of body mass index and type 2 diabetes in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma” [EJC Skin Cancer 3 (2025) 100284]
Corrigendum to “PTHrP-induced hypercalcemic psychosyndrome under combined anti-PD-L1 and anti-EGFR inhibition in penile squamous cell carcinoma – A case report” [EJC Skin Cancer 2 (2024) 100261]
Corrigendum to “Efficacy of neoadjuvant pembrolizumab in a primary cutaneous stage II non-operated melanoma” [EJC Skin Cancer 2 (2024) 100028]
Erratum to: “Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab vs placebo in resected stage III melanoma” [EJC Skin Cancer 3 (2025) 100727]
Erratum to: “Patterns of systemic treatment for melanoma: An insight on trends and costs between 2019–2023 from the english systemic anti-cancer therapy national database,” [EJC Skin Cancer 3 (2025), 100279]
Erratum to: Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma journal: EJC skin cancer [Vol. 4, 2026, 100775]
Erratum to “CLAUDIUS Study: Risk of materno-fetal transmission of melanoma cells in pregnant women with high grade melanoma – A retrospective multicenter study and literature review” [EJC Skin Cancer 1 (2023) 100005]
Erratum to "Response to Letter Re: 'Comparative analysis of international melanoma guidelines'" [EJC Skin Cancer 3 (2025) 100752]
Erratum to: Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab vs placebo in resected stage III melanoma. [EJC Skin Cancer, Volume 3, 2025, 100727]
Erratum to “Comparative analysis of international melanoma guidelines” [EJC Skin Cancer 3 (2025) 100732]
BRAF/MEK inhibitor rechallenge in patients with non-resectable or metastatic BRAF V600-mutated melanoma: A stratified, controlled, retrospective EUMelaReg multicenter study
99Tc-Tilmanocept sentinel node biopsy and long-term outcomes in melanoma
A case of Lentigo Maligna presenting as repigmentation of hair in a scalp that previously underwent radiotherapy for tinea capitis
A case of melanoma arising in a long-standing intradermal nevus.
A novel clinical clue in the evaluation of nodular lesions
A novel prognostic model for patients with metastatic cutaneous melanoma
A randomized, controlled, multicenter, phase 3 study of RP1 (vusolimogene oderparepvec) combined with nivolumab vs physician’s choice of therapy in patients with advanced melanoma that has progressed on anti–PD-1 and anti–CTLA-4 therapy (IGNYTE-3)
A randomized, phase 2/3 clinical trial investigating RP2 plus nivolumab vs ipilimumab plus nivolumab in immune checkpoint inhibitor–naïve patients with metastatic uveal melanoma
A study of residual lesions in the wide local excision of melanoma in situ
Abscopal effect of intratumoral therapy with daromun in locally advanced and lymphogenically metastasised malignant melanoma
Add-on of anti-PD-1 therapy to BRAF/MEK inhibition in patients with poor-prognosis stage IV BRAFV600-mutant melanoma, a retrospective case series
Adjuvant therapy with locoregional interferon-beta versus surgery alone for resected stage II/III cutaneous melanoma: A multicenter randomized phase III trial (JCOG1309, J-FERON)
Advances in Non-contact dermoscopic imaging: optical, computational and clinical perspectives in melanoma diagnosis
Artificial intelligence-based smartphone app for skin cancer detection: a prospective diagnostic accuracy study
Balancing Oncologic Safety and Functional Preservation in Acral Melanoma:Outcomes of Slow Mohs Micrographic Surgery and Reconstruction
Biomarker and updated clinical data for RP1 plus nivolumab in anti–PD-1–failed melanoma from the IGNYTE trial demonstrate reversal of mechanisms of resistance to immune checkpoint blockade
Bone metastases in melanoma: a real-world clinical and radiological descriptive analysis
EUVIMED